BDX Q1 2019 Earnings — Becton, Dickinson and Company Revenue & Financial Results | Market Cap Arena

BDXBecton, Dickinson and Company

$59B

Q1 2019 Earnings

Healthcare Medical - Instruments & Supplies

Income Statement

Revenue

$4.2B+35.1% YoY

Gross Profit

$2.0B47.4% margin

Operating Income

$888M21.3% margin

Net Income

$599M14.4% margin

EPS (Diluted)

$2.05

QoQ Revenue Growth

-5.5%

Cash Flow

Operating Cash Flow

$246M

Free Cash Flow

$79M

Stock-Based Comp.

$93M

Balance Sheet

Total Assets

$52.9B

Total Liabilities

$31.5B

Stockholders' Equity

$21.4B

Cash & Equivalents

$943M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$4.2B	$3.1B	+35.1%
Gross Profit	$2.0B	$1.6B	+27.0%
Operating Income	$888M	$235M	+277.9%
Net Income	$599M	-$136M	+540.4%

Revenue Segments

Medical

$2.1B51%

Life Sciences

$1.1B25%

Interventional

$970M23%

Geographic Segments

UNITED STATES

$2.4B57%

Non-US

$1.8B43%